Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,972 public trials 2,027 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

NCT00003368

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
View all 45 locations
View Trial Details
Completed

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

NCT00996957

Conditions
Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations
  • Acceleron Investigative Site Scottsdale, Arizona, United States
  • Acceleron Investigative Site Durham, North Carolina, United States
  • Acceleron Investigative Site Nashville, Tennessee, United States
  • Acceleron Investigative Site Salt Lake City, Utah, United States
View Trial Details
Completed

CP-751,871 Treatment For Patients With Multiple Myeloma

NCT01536145

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Scottsdale, Arizona, United States
  • Pfizer Investigational Site Tampa, Florida, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
View Trial Details

Related conditions